DE69721247D1 - Wasserlösliche trisubstituierte 1,2-dioxetanverbindungen mit erhöhter lagerstabilität, syntheseverfahren und zwischenverbindungen - Google Patents

Wasserlösliche trisubstituierte 1,2-dioxetanverbindungen mit erhöhter lagerstabilität, syntheseverfahren und zwischenverbindungen

Info

Publication number
DE69721247D1
DE69721247D1 DE69721247T DE69721247T DE69721247D1 DE 69721247 D1 DE69721247 D1 DE 69721247D1 DE 69721247 T DE69721247 T DE 69721247T DE 69721247 T DE69721247 T DE 69721247T DE 69721247 D1 DE69721247 D1 DE 69721247D1
Authority
DE
Germany
Prior art keywords
dioxetanes
water
storage stability
substituted
synthesis procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69721247T
Other languages
English (en)
Other versions
DE69721247T2 (de
Inventor
Hashem Akhavan-Tafti
Zahra Arghavani
Renuka Desilva
Kumar Thakur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lumigen Inc
Original Assignee
Lumigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25008049&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69721247(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lumigen Inc filed Critical Lumigen Inc
Publication of DE69721247D1 publication Critical patent/DE69721247D1/de
Application granted granted Critical
Publication of DE69721247T2 publication Critical patent/DE69721247T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Luminescent Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polyethers (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69721247T 1996-11-08 1997-11-07 Wasserlösliche trisubstituierte 1,2-dioxetanverbindungen mit erhöhter lagerstabilität, syntheseverfahren und zwischenverbindungen Expired - Lifetime DE69721247T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/748,107 US5721370A (en) 1995-07-31 1996-11-08 Water soluble tri-substituted 1,2-dioxetane compounds and assay compositions having increased storage stability
US748107 1996-11-08
PCT/US1997/019618 WO1998019989A1 (en) 1996-11-08 1997-11-07 Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates

Publications (2)

Publication Number Publication Date
DE69721247D1 true DE69721247D1 (de) 2003-05-28
DE69721247T2 DE69721247T2 (de) 2004-03-11

Family

ID=25008049

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69721247T Expired - Lifetime DE69721247T2 (de) 1996-11-08 1997-11-07 Wasserlösliche trisubstituierte 1,2-dioxetanverbindungen mit erhöhter lagerstabilität, syntheseverfahren und zwischenverbindungen

Country Status (13)

Country Link
US (2) US5721370A (de)
EP (1) EP0898557B9 (de)
JP (1) JP4199830B2 (de)
KR (1) KR100518977B1 (de)
CN (1) CN1252029C (de)
AT (1) ATE238268T1 (de)
AU (1) AU734753B2 (de)
CA (1) CA2238365C (de)
DE (1) DE69721247T2 (de)
DK (1) DK0898557T3 (de)
ES (1) ES2197376T3 (de)
IL (1) IL124671A (de)
WO (1) WO1998019989A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856522A (en) * 1995-05-04 1999-01-05 Tropix, Inc. Method of using synthesis of 1,2-dioxetanes and kits therefore
US5578253A (en) * 1994-11-23 1996-11-26 Lumigen, Inc. Chemiluminescent dialkyl-substituted 1,2-dioxetane compounds, methods of synthesis and use
DE69622605T2 (de) * 1995-10-17 2003-03-13 Tropix Inc Chemilumineszente 1,2-dioxetane mit verbesserter leistung
CN1211387C (zh) * 1998-09-08 2005-07-20 布里奇·P·吉利 化学发光的1,2-二氧丁环
US6555698B1 (en) * 1998-11-17 2003-04-29 Tropix, Inc. Chemiluminescent substrates for neuraminidase, assays for detection of neuraminidase and kits therefor
US6623971B2 (en) * 1999-01-11 2003-09-23 Bayer Corporation Method and apparatus for conducting a stat immunoassay analysis in a capsule chemistry analysis system
US6783948B1 (en) * 1999-07-30 2004-08-31 Bayer Corporation Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes
WO2006116683A1 (en) * 2005-04-27 2006-11-02 The Trustees Of The University Of Pennsylvania Nanostructure enhanced luminescence
WO2006116686A2 (en) * 2005-04-27 2006-11-02 The Trustees Of The University Of Pennsylvania Nanostructure enhanced luminescent devices
WO2006116687A2 (en) * 2005-04-27 2006-11-02 The Trustees Of The University Of Pennsylvania Nanoassays

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004565A (en) * 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US4983779A (en) * 1986-07-17 1991-01-08 The Board Of Governors Of Wayne State University Process for the preparation of vinyl ethers
US4959182A (en) * 1986-07-17 1990-09-25 Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US5013827A (en) * 1986-07-17 1991-05-07 Board Of Governors Of Wayne State University Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers
US5068339A (en) * 1986-07-17 1991-11-26 Board Of Governors Of Wayne State University Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers
US5220005A (en) * 1986-07-24 1993-06-15 Tropix, Inc. Substituted adamantyl dioxetanes
DE3788203T2 (de) * 1986-07-24 1994-03-31 Tropix Inc Verfahren zum nachweis einer verbindung unter verwendung des enzymatisch induzierten zerfalls von dioxethanen.
CA1340590C (en) * 1986-07-24 1999-06-08 John C. Voyta Chemiluminescence enhancement
US5112960A (en) * 1989-07-17 1992-05-12 Bronstein Irena Y Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes
US5582980A (en) * 1989-07-17 1996-12-10 Tropix, Inc. Chemiluminescent 1,2-dioxetanes
US4952707A (en) * 1988-06-30 1990-08-28 Tropix, Inc. Enzymatically-cleavable chemiluminescent fused polycyclic ring-containing 1,2-dioxetanes
US5547836A (en) * 1990-08-30 1996-08-20 Tropix, Inc. Enhancement of chemiluminescent assays
DE473984T1 (de) * 1990-09-07 1992-08-13 The Board Of Governors Of Wayne State University, Detroit, Mich. 1,2-dioxetan-verbindungen als chemilumineszierende markierungen fuer organische und biologische molekuele.
US5399497A (en) * 1992-02-26 1995-03-21 Miles, Inc. Capsule chemistry sample liquid analysis system and method
US5393469A (en) * 1992-03-20 1995-02-28 Lumigen, Inc. Polymeric phosphonium salts providing enhanced chemiluminescence from 1,2-dioxetanes
AU5132993A (en) * 1992-09-21 1994-04-12 Habley Medical Technology Corporation Device and method for containing an ampule and transferring liquid within the ampule to a container
US5603868A (en) * 1992-10-30 1997-02-18 Abbott Laboratories Chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes
US5451347A (en) * 1993-06-24 1995-09-19 Lumigen, Inc. Methods and compositions providing enhanced chemiluminescence from chemiluminescent compounds using dicationic surfactants
US5631167A (en) * 1995-07-31 1997-05-20 Bayer Corporation Capsule chemistry analytical methods employing dioxetane chemiluminescence
US5777135A (en) * 1995-07-31 1998-07-07 Lumigen, Inc. Di-substituted 1,2-dioxetane compounds having increased water solubility and assay compositions

Also Published As

Publication number Publication date
AU6990798A (en) 1998-05-29
KR100518977B1 (ko) 2006-06-29
IL124671A (en) 2003-01-12
US5866045A (en) 1999-02-02
WO1998019989A1 (en) 1998-05-14
EP0898557B9 (de) 2003-10-08
AU734753B2 (en) 2001-06-21
KR19990077111A (ko) 1999-10-25
CA2238365C (en) 2008-03-18
ATE238268T1 (de) 2003-05-15
CN1208399A (zh) 1999-02-17
EP0898557A4 (de) 2001-01-10
CN1252029C (zh) 2006-04-19
CA2238365A1 (en) 1998-05-14
US5721370A (en) 1998-02-24
EP0898557A1 (de) 1999-03-03
EP0898557B1 (de) 2003-04-23
DE69721247T2 (de) 2004-03-11
DK0898557T3 (da) 2003-08-04
IL124671A0 (en) 1998-12-06
JP2000506544A (ja) 2000-05-30
ES2197376T3 (es) 2004-01-01
JP4199830B2 (ja) 2008-12-24

Similar Documents

Publication Publication Date Title
DE68925963D1 (de) Chemilimineszente 1,2-Dioxetan-Verbindungen
DE69721247D1 (de) Wasserlösliche trisubstituierte 1,2-dioxetanverbindungen mit erhöhter lagerstabilität, syntheseverfahren und zwischenverbindungen
DE69900813D1 (de) Asymmetrische cyaninfarbstoffe als fluoreszenzlöscher
EA200201096A1 (ru) СОЕДИНЕНИЯ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ ИММУНОДЕПРЕССАНТОВ
EA200100139A1 (ru) Фармацевтические композиции, содержащие 2-хинолоны
CA2186618A1 (en) Novel aryl-n-alkylacridanthiocarboxylate derivatives useful for chemiluminescent detection
KR910000991A (ko) 화학발광선을 생성시키기 위한 조성물 및 그이 생성 방법
EA200200912A1 (ru) Новые производные индолин-2-она, их получение и их применение в качестве лигандов рецепторов окситоцина
TNSN98075A1 (fr) Analogues peptidiques de la lh-rh, leur utilisation et les compositions pharmaceutiques les contenant.
EA199800103A1 (ru) Дигликозилированные 1,2-диолы как псевдосоединения сиалил-lewis x и сиалил-lewis a
ES2189844T3 (es) Compuestos de 1,2-dioxetanos sustituidos que presentan una solubilidad en agua aumentada y composiciones de prueba.
EA199700160A1 (ru) Производные индола в качестве антагонистов eaa
KR920703512A (ko) 단백질 활성효소 c(protein kinase c)를 방해하는 1, 4-비스-(아미노-하이드록시알킬아미노)-안트라퀴논
ATE451378T1 (de) Chemolumineszente 1,2-dioxetane
EP0078703A3 (de) Markierte Pyroglu-L-Phe-L-Arg-Derivate, Substrate und Methoden zur Bestimmung von Kallikrein
SE8503415L (sv) Nya isoindolinylalkylpiperaziner och farmaceutiska kompositioner innehallande desamma
DK0757248T3 (da) Forbedrede kapsel-kemi analytiske metoder, der benytter dioxetan-kemiluminescens
EA199700223A1 (ru) Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
EA200100829A1 (ru) Легкие экструдированные композиции, содержащие легкий экструдируемый керамический носитель, способы их применения и способы их приготовления
KR900000345A (ko) 1-할로 1-아졸일에탄유도체 및 이들을 함유하는 살균제
EA200301062A1 (ru) Фармацевтические комбинации на основе производных пиридоиндолона и противораковых агентов
EA199900054A1 (ru) Меченные 19 фтором производные антрациклинона и антрациклина
EA199900688A1 (ru) Хиноксалиндионы
KR920018523A (ko) 포지티브 레지스트 조성물
FI901046A0 (fi) Stabilisering av polyprenylfoereningen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition